$UUU
UNIVERSAL SECURITY INSTRUMENTS INC

2015 Q3 Form 10-Q Financial Statement

#000114420415057285 Filed on September 28, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q2 2014 Q2
Revenue $3.278M $2.936M $2.514M
YoY Change 47.41% 16.79% -16.35%
Cost Of Revenue $2.590M $2.050M $1.900M
YoY Change 49.71% 7.89% -15.93%
Gross Profit $684.7K $882.4K $611.5K
YoY Change 38.73% 44.31% -18.39%
Gross Profit Margin 20.88% 30.05% 24.32%
Selling, General & Admin $1.154M $1.164M $1.187M
YoY Change 3.09% -2.0% 8.97%
% of Gross Profit 168.53% 131.88% 194.2%
Research & Development $147.1K $200.3K $162.0K
YoY Change -43.41% 23.67% 27.9%
% of Gross Profit 21.49% 22.7% 26.49%
Depreciation & Amortization $10.00K $9.385K $11.74K
YoY Change 0.0% -20.04% 15.75%
% of Gross Profit 1.46% 1.06% 1.92%
Operating Expenses $1.301M $1.364M $1.349M
YoY Change -5.67% 1.08% 10.94%
Operating Profit -$616.3K -$481.7K -$738.0K
YoY Change -30.42% -34.73% 58.0%
Interest Expense $210.0K -$300.0K $0.00
YoY Change -191.3% -100.0%
% of Operating Profit
Other Income/Expense, Net -$4.701K -$8.282K
YoY Change
Pretax Income -$4.701K -$777.1K -$742.8K
YoY Change -150.29% 4.61% 293.88%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$411.3K -$777.1K -$742.8K
YoY Change -63.02% 4.61% 3703.63%
Net Earnings / Revenue -12.55% -26.46% -29.54%
Basic Earnings Per Share -$0.34 -$0.32
Diluted Earnings Per Share -$177.5K -$0.34 -$0.32
COMMON SHARES
Basic Shares Outstanding 2.313M shares 2.313M shares 2.313M shares
Diluted Shares Outstanding 2.313M shares 2.313M shares

Balance Sheet

Concept 2015 Q3 2015 Q2 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $150.0K $250.0K $2.960M
YoY Change -94.62% -91.55% 98.66%
Cash & Equivalents $148.8K $253.4K $2.957M
Short-Term Investments
Other Short-Term Assets $340.0K $480.0K $350.0K
YoY Change -10.53% 37.14% -45.31%
Inventory $4.510M $4.680M $3.530M
Prepaid Expenses
Receivables $530.0K $930.0K $520.0K
Other Receivables $1.480M $1.330M $1.090M
Total Short-Term Assets $7.000M $7.670M $8.440M
YoY Change -8.3% -9.12% -15.67%
LONG-TERM ASSETS
Property, Plant & Equipment $90.00K $100.0K $135.6K
YoY Change -25.0% -26.25% -5.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.74M $12.56M $14.13M
YoY Change -8.48% -11.07% -5.82%
Other Assets $10.00K $30.00K $38.13K
YoY Change -75.0% -21.33% 0.0%
Total Long-Term Assets $12.90M $12.76M $14.37M
YoY Change -8.88% -11.25% -18.96%
TOTAL ASSETS
Total Short-Term Assets $7.000M $7.670M $8.440M
Total Long-Term Assets $12.90M $12.76M $14.37M
Total Assets $19.90M $20.43M $22.81M
YoY Change -8.67% -10.47% -17.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.310M $1.940M $712.2K
YoY Change 67.95% 172.39% 21.39%
Accrued Expenses $150.0K $170.0K $220.0K
YoY Change -48.28% -22.73% 57.14%
Deferred Revenue
YoY Change
Short-Term Debt $1.000M $430.0K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.460M $2.540M $1.000M
YoY Change 129.91% 154.0% 15.41%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $30.00K
YoY Change -100.0% -100.0% 20.0%
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $30.00K
YoY Change -100.0% -100.0% 20.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.460M $2.540M $1.000M
Total Long-Term Liabilities $0.00 $0.00 $30.00K
Total Liabilities $2.460M $2.540M $1.030M
YoY Change 123.64% 146.6% 15.54%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $12.91M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.44M $17.89M $21.79M
YoY Change
Total Liabilities & Shareholders Equity $19.90M $20.43M $22.81M
YoY Change -9.34% -10.43% -17.79%

Cashflow Statement

Concept 2015 Q3 2015 Q2 2014 Q2
OPERATING ACTIVITIES
Net Income -$411.3K -$777.1K -$742.8K
YoY Change -63.02% 4.61% 3703.63%
Depreciation, Depletion And Amortization $10.00K $9.385K $11.74K
YoY Change 0.0% -20.04% 15.75%
Cash From Operating Activities -$680.0K -$854.7K $906.5K
YoY Change 300.0% -194.29% -195.34%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 570.0K $426.7K $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -680.0K -$854.7K $906.5K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities 570.0K $426.7K $0.00
Net Change In Cash -110.0K -$428.0K $906.5K
YoY Change -35.29% -147.21% -195.34%
FREE CASH FLOW
Cash From Operating Activities -$680.0K -$854.7K $906.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
23129 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
253362 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49427 USD
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12885841 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
23129 USD
CY2015Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
64288 USD
CY2015Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
111020 USD
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
107257 USD
CY2015Q2 us-gaap Assets
Assets
20427152 USD
CY2015Q1 us-gaap Assets
Assets
19906028 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
70429 USD
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
71547 USD
CY2015Q2 us-gaap Equity Method Investments
EquityMethodInvestments
12562630 USD
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1163786 USD
CY2015Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
-8282 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2936490 USD
CY2014Q2 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
1710999 USD
CY2015Q2 uuu Cost Of Goods Sold Acquired From Joint Venture
CostOfGoodsSoldAcquiredFromJointVenture
1911257 USD
CY2015Q2 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
142806 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
882427 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
161964 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
200303 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-742849 USD
CY2015Q1 uuu Funds Held By Factor
FundsHeldByFactor
631906 USD
CY2015Q2 uuu Funds Held By Factor
FundsHeldByFactor
0 USD
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9385 USD
CY2015Q2 uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
470055 USD
CY2015Q2 us-gaap Interest Paid
InterestPaid
9785 USD
CY2015Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
964984 USD
CY2015Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-427971 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2957497 USD
CY2015Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014Q2 uuu Cost Of Goods Sold Other
CostOfGoodsSoldOther
191898 USD
CY2014Q2 us-gaap Gross Profit
GrossProfit
611488 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
6024586 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2050993 USD
CY2014Q2 us-gaap Interest Paid
InterestPaid
0 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-481662 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-737967 USD
CY2014Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12527 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
381254 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1187491 USD
CY2014Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
7645 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-730322 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-742849 USD
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887 shares
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-489944 USD
CY2015Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-287133 USD
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-777077 USD
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-777077 USD
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2312887 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887 shares
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2514385 USD
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2312887 shares
CY2014Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
14597 USD
CY2015Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 USD
CY2014Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-20388 USD
CY2015Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-93515 USD
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-748640 USD
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-870592 USD
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11737 USD
CY2014Q2 uuu Increase Decrease In Accounts Receivable And Due From Factor
IncreaseDecreaseInAccountsReceivableAndDueFromFactor
-681394 USD
CY2014Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
218669 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
906504 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-854703 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2014Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
906594 USD
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2015Q2 uuu Increase Decrease In Inventories And Prepaid Expenses
IncreaseDecreaseInInventoriesAndPrepaidExpenses
869073 USD
CY2014Q2 uuu Increase Decrease In Inventories And Prepaid Expenses
IncreaseDecreaseInInventoriesAndPrepaidExpenses
-725026 USD
CY2014Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015Q2 dei Document Type
DocumentType
10-Q
CY2015Q2 dei Amendment Flag
AmendmentFlag
false
CY2015Q2 dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
CY2015Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2015Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q2 dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL SECURITY INSTRUMENTS INC
CY2015Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000102109
CY2015Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2015Q2 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q2 dei Trading Symbol
TradingSymbol
UUU
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2312887 shares
CY2015Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
991807 USD
CY2015Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
571012 USD
CY2015Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
426732 USD
CY2015Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 USD
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2312887 shares
CY2015Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
426732 USD
CY2015Q2 uuu Products Purchased From Joint Venture
ProductsPurchasedFromJointVenture
2753772 USD
CY2014Q2 uuu Products Purchased From Joint Venture
ProductsPurchasedFromJointVenture
1076376 USD
CY2014Q2 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2015Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
426732 USD
CY2014Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
4612505 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
3664900 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
366307 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
939947 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
11740633 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
17237635 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-784927 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-121206 USD
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
31066085 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
35671149 USD
CY2014Q2 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
7359434 USD
CY2015Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.5 pure
CY2015Q2 uuu Increase Or Decrease In Inter Company Profit In Inventory
IncreaseOrDecreaseInInterCompanyProfitInInventory
105329 USD
CY2014Q2 uuu Increase Or Decrease In Inter Company Profit In Inventory
IncreaseOrDecreaseInInterCompanyProfitInInventory
48076 USD
CY2014Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.5 pure
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
57000 USD
CY2015Q2 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
bear interest at the prime commercial rate of interest, as published, plus two percent (Effective rate 3.25% at June 30, 2015).
CY2015Q2 us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
The agreement replaces the financing and factoring agreement with CIT which was terminated on the same date. In accordance with the provisions of the Discount Factoring Agreement with Merchant, the Company may take advances, recorded as a liability of the Company, equal to eighty percent (80%) of the factored trade accounts receivable balance less applicable factoring commissions. Additionally, the Discount Factoring Agreement with Merchant enables the Company to borrow up to fifty percent (50%) of eligible inventories subject to a borrowing limitation on inventory of $1,000,000.
CY2015Q2 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
814409 USD
CY2015Q1 us-gaap Accounts Payable Related Parties Current And Noncurrent
AccountsPayableRelatedPartiesCurrentAndNoncurrent
299985 USD
CY2015Q2 us-gaap Line Of Credit
LineOfCredit
426732 USD

Files In Submission

Name View Source Status
0001144204-15-057285-index-headers.html Edgar Link pending
0001144204-15-057285-index.html Edgar Link pending
0001144204-15-057285.txt Edgar Link pending
0001144204-15-057285-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tex99-1logo.jpg Edgar Link pending
uuu-20150630.xml Edgar Link completed
uuu-20150630.xsd Edgar Link pending
uuu-20150630_cal.xml Edgar Link unprocessable
uuu-20150630_def.xml Edgar Link unprocessable
uuu-20150630_lab.xml Edgar Link unprocessable
uuu-20150630_pre.xml Edgar Link unprocessable
v420711_10q.htm Edgar Link pending
v420711_ex31-1.htm Edgar Link pending
v420711_ex31-2.htm Edgar Link pending
v420711_ex32-1.htm Edgar Link pending
v420711_ex99-1.htm Edgar Link pending